CollPlant Biotechnologies , a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and ...

Amgen today announced new interim results from the global Phase 3 DeLLphi-304 trial showing IMDELLTRA® (tarlatamab-dlle) reduced the risk of death by 40% and significantly extended median overall ...

We are pleased to share the May 2025 issue of Wilson Sonsini’s Sustainability and ESG Advisory Practice Update. Each issue combines news, key ...

There’s a profound difference between depriving yourself—believing certain foods are off-limits because they’re “bad”—and ...

Roaches played a role in the temporarily closure of one cafe, and a few other inspections that failed to meet standards.

AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers regardless of eosinophilic phenotype and provided a clinically me ...

AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers rega ...

About itepekimab Itepekimab is a fully human monoclonal antibody that binds to and inhibits interleukin-33 (IL33), an initiator and amplifier of broad inflammation in COPD. IL33 is thought to be ...

Q1 2025 highlighted the growing traction of the company's data collection solutions with leading AI and eCommerce players worldwide Company strategically accelerated investments in scalable infrastruc ...

Q1 2025 highlighted the growing traction of the company's data collection solutions with leading AI and eCommerce players worldwide Company ...